Chemoinformaics analysis of Adenostemmoic acid G
| Molecular Weight | 350.455 | nRot | 2 |
| Heavy Atom Molecular Weight | 320.215 | nRig | 22 |
| Exact Molecular Weight | 350.209 | nRing | 6 |
| Solubility: LogS | -3.404 | nHRing | 2 |
| Solubility: LogP | 1.955 | No. of Aliphatic Rings | 6 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 55 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 25 | No. of Aromatic Carbocycles | 0 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 4 | No. Saturated Carbocycles | 4 |
| No. of Hydrogen atom | 30 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 6 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 57.4138 |
| nHD | 3 | BPOL | 32.7002 |
| QED | 0.711 |
| Synth | 6.534 |
| Natural Product Likeliness | 3.542 |
| NR-PPAR-gamma | 0.033 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.854 |
| Pgp-sub | 0.283 |
| HIA | 0.016 |
| CACO-2 | -5.29 |
| MDCK | 0.0000299 |
| BBB | 0.618 |
| PPB | 0.575872 |
| VDSS | 0.349 |
| FU | 0.33617 |
| CYP1A2-inh | 0.008 |
| CYP1A2-sub | 0.612 |
| CYP2c19-inh | 0.005 |
| CYP2c19-sub | 0.601 |
| CYP2c9-inh | 0.007 |
| CYP2c9-sub | 0.056 |
| CYP2d6-inh | 0.007 |
| CYP2d6-sub | 0.131 |
| CYP3a4-inh | 0.131 |
| CYP3a4-sub | 0.085 |
| CL | 3.09 |
| T12 | 0.596 |
| hERG | 0.049 |
| Ames | 0.076 |
| ROA | 0.913 |
| SkinSen | 0.932 |
| Carcinogencity | 0.815 |
| EI | 0.316 |
| Respiratory | 0.976 |
| NR-Aromatase | 0.474 |
| Antiviral | Yes |
| Prediction | 0.558202 |